 Future directions management cytomegalovirus infections Ganciclovir agent use treatment cytomegalovirus CMV retinitis immunocompromised patients immune deficiency syndrome AIDS effect CMV vitro vivo usefulness types CMV infection Investigations use agent treatment AIDS patients CMV gastrointestinal disease treatment prevention CMV disease transplant recipients studies issues important management patients ganciclovir therapy Particular objectives scope ganciclovir resistance CMV prospects tolerance coadministered ganciclovir zidovudine plausibility drug delivery concomitant use recombinant human granulocyte-macrophage colony-stimulating factor oral administration agent